Report Highlights
The global sepsis diagnostic market should reach $837 million by 2026 from $587.6 million in 2021 at a compound annual growth rate (CAGR) of 7.3% for the forecast period of 2021 to 2026.
Report Includes
- 35 data tables and 15 additional tables
- An updated overview of the global sepsis diagnostics market
- Analyses of the global market trends, with data from 2019 to 2021, and projections of compound annual growth rates (CAGRs) through 2026
- Evaluation and forecast the global market size for sepsis diagnostics, and corresponding market share analysis by product, technology type, diagnostic method, test type, pathogen, end user and geographic region
- Highlights the current and future market potential of sepsis diagnostics along with a detailed analysis of the drivers, challenges, and opportunities in the market
- Identification of promising new products and technologies still in the development and assess the probability that they will be commercialized successfully in the next five years
- Discussion of the COVID-19 implications on the market for sepsis clinical diagnostics and research studies
- Information pertaining to the companies best positioned to meet this demand owing to their proprietary technologies, mergers and acquisitions, joint ventures and other strategic alliances
- Insight into the recent industry structure, current competitive scenario, R&D activities, product launch strategies and company value share analysis based on their segmental revenues
- Descriptive company profiles of the leading global players, including Abbott Laboratories, Bruker Corp., Roche Diagnostics Corp., Siemens Healthineers AG and Thermo Fisher Scientific Inc.
Report Scope
The current report provides detailed exposure to the sepsis diagnostic market. This report highlights the current and future market potential of sepsis diagnostics, as well as a detailed analysis of market drivers, challenges and opportunities. The report also covers market projections to 2026 and market shares for key market players. It details the market share of sepsis diagnostics based on technology type, product, diagnostic method and pathogen type. The report includes company profiles of the key players, with detailed information regarding their business segments, financials, product portfolios and recent developments. The report also provides the impact of the COVID-19 pandemic on this market.
The regional market has been segmented into North America, Europe, Asia-Pacific and the Rest of the world. For market estimates, data have been provided for 2019 as the historic year and 2020 as the base year, with a forecast for 2026.
Report Synopsis
| Report Metrics | Details | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2020 | ||||||||||||||||
| Forecast period considered | 2021-2026 | ||||||||||||||||
| Base year market size | $548.9 million | ||||||||||||||||
| Market size forecast | $837.0 million | ||||||||||||||||
| Growth rate | CAGR of 7.3% from 2021 to 2026 | ||||||||||||||||
| Units considered | $ Millions | ||||||||||||||||
| Segments covered | Method Type, Test Type, Pathogen Type, End User, | ||||||||||||||||
| Regions covered | North America, Europe, Asia-Pacific, Rest of the World (RoW) | ||||||||||||||||
| Key Market Drivers |
|
||||||||||||||||
| Companies studied |
|
||||||||||||||||
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
- Global Electric Vehicle Battery Reuse and Recycling Market (FCB058B)
- Artificial Intelligence (AI) in Cancer (BIO196B)
- Nutraceuticals: Global Markets (FOD013J)
- Protective Relays and Circuit Breakers: Global Markets (IAS157B)
- Global Market Opportunities and Competitive Landscape for CDMO (PHM238B)
Related Reports
Global Markets for Infectious Disease Treatments
The global market for infectious disease treatments should grow from $72.4 billion in 2021 to $106.3 billion by 2026, at compound annual growth rate (CAGR) of 8.0% for the period of 2021-2026.
Healthcare-Acquired Infections: Devices, Pharmaceuticals, and Environmental Products
The global market HCAI Control should grow from $24.0 billion in 2021 to $36.2 billion by 2026, at compound annual growth rate (CAGR) of 8.6% for the period of 2021-2026.
Blood Testing: Technologies and Global Markets
The global market for blood testing will grow from nearly $53.8 billion in 2018 to $60.5 billion by 2023 with a compound annual growth rate (CAGR) of 2.4% for the period of 2018-2023.
Recent Reports
Artificial Intelligence (AI) in Cancer
The global market for artificial intelligence (AI) in cancer is estimated to increase from $2.2 billion in 2024 to reach $6.3 billion by 2029, at a compound annual growth rate (CAGR) of 23.1% from 2024 through 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Induced Pluripotent Stem Cells: Global Markets
The global market for induced pluripotent stem cells (iPSCs) is expected to grow from $3.4 billion in 2023 to reach $5.2 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.1% from 2023 to 2028.
Commercial Amino Acids
The global market for commercial amino acids was valued at $30.1 billion in 2023. It is expected to grow from $31.8 billion in 2024 to $42.8 billion by 2029, at a compound annual growth rate (CAGR) of 6.1% from 2024 through 2029.
Top Trending Reports
AI in Clinical and Molecular Diagnostics Market
The global market for AI in clinical and molecular diagnostics is expected to grow from $2.6 billion in 2024 and is projected to reach $8.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.6% during the forecast period of 2024 to 2029.
Point-of-Care Diagnostics: Technologies and Global Markets
The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Artificial Intelligence (AI) Market: Investments vs Potential
The global market for artificial intelligence (AI) is estimated to increase from $148.8 billion in 2023 to reach $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 39.7% from 2024 through 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More